Literature DB >> 17728543

Methamphetamine-associated acute left ventricular dysfunction: a variant of stress-induced cardiomyopathy.

Sundararajan Srikanth1, Rajat Barua, John Ambrose.   

Abstract

This brief report describes a case of transient left ventricular dysfunction in a 42-year-old woman associated with methamphetamine abuse. Transient (stress-induced) left ventricular dysfunction has been described previously, usually in postmenopausal women following emotional stress and also severe medical illness. This is the first reported case associated with methamphetamine abuse. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17728543     DOI: 10.1159/000106681

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  9 in total

1.  Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance.

Authors:  Javier E Lopez; Khung Yeo; Gary Caputo; Michael Buonocore; Saul Schaefer
Journal:  J Cardiovasc Magn Reson       Date:  2009-11-11       Impact factor: 5.364

Review 2.  Methamphetamine-associated cardiomyopathy.

Authors:  Sekon Won; Robert A Hong; Ralph V Shohet; Todd B Seto; Nisha I Parikh
Journal:  Clin Cardiol       Date:  2013-08-27       Impact factor: 2.882

3.  Uncharted waters: rare and unclassified cardiomyopathies characterized on cardiac magnetic resonance imaging.

Authors:  Ailbhe C O'Neill; Shaunagh McDermott; Carole A Ridge; Kenneth McDonald; David Keane; Jonathan D Dodd
Journal:  Insights Imaging       Date:  2010-10-19

Review 4.  Cathinone neurotoxicity ("The "3Ms").

Authors:  Steven B Karch
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

5.  Untargeted Metabolomic Analysis of Rat Neuroblastoma Cells as a Model System to Study the Biochemical Effects of the Acute Administration of Methamphetamine.

Authors:  Garth L Maker; Tobias Green; Ian Mullaney; Robert D Trengove
Journal:  Metabolites       Date:  2018-06-07

6.  Hemodynamic Effects of Methamphetamine and General Anesthesia.

Authors:  Keyvan M Safdari; Curtis Converse; Fanglong Dong; Nickolas Alan MacDougall; Kevin Hyer; Alec Runyon; Haley Ahlering; Mark E Comunale
Journal:  Anesthesiol Res Pract       Date:  2022-02-17

7.  Report of methamphetamine use and cardiomyopathy in three patients.

Authors:  Roxana Sadeghi; Khosro Agin; Maryam Taherkhani; Leila Najm-Afshar; Lewis S Nelson; Mohammad Abdollahi; Shahin Shadnia
Journal:  Daru       Date:  2012-08-30       Impact factor: 3.117

8.  Methamphetamine-induced occludin endocytosis is mediated by the Arp2/3 complex-regulated actin rearrangement.

Authors:  Minseon Park; Hyun-Jung Kim; Brian Lim; Adam Wylegala; Michal Toborek
Journal:  J Biol Chem       Date:  2013-09-30       Impact factor: 5.157

Review 9.  Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy: State-of-the-Art Review.

Authors:  Pavan K V Reddy; Tien M H Ng; Esther E Oh; Gassan Moady; Uri Elkayam
Journal:  J Am Heart Assoc       Date:  2020-05-29       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.